Evidence map›Paper›PMID 24285264›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2014

Deregulation of the lysyl hydroxylase matrix cross-linking system in experimental and clinical bronchopulmonary dysplasia.

Thilo J Witsch, Pawel Turowski, Elpidoforos Sakkas, Gero Niess, Simone Becker, Susanne Herold, Konstantin Mayer, István Vadász, Jesse D Roberts, Werner Seeger and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Lysyl oxidase regulation and protein aldehydes in the injured newborn lung.American journal of physiology. Lung cellular and molecular physiology · 2022
    Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Extracellular matrix in lung development, homeostasis and disease.Matrix biology : journal of the International Society for Matrix Biology · 2018
    Review
  13. Article
  14. Review
  15. LungMAP: The Molecular Atlas of Lung Development Program.American journal of physiology. Lung cellular and molecular physiology · 2017
    Review
  16. Article
  17. Review
  18. Review
  19. Searching for better animal models of BPD: a perspective.American journal of physiology. Lung cellular and molecular physiology · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Thilo J WitschDept. of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, Parkstrasse 1, D-61231 Bad Nauheim, Germany. rory.morty@mpi-bn.mpg.de.
Pawel Turowski
Elpidoforos Sakkas
Gero Niess
Simone Becker
Susanne Herold
Konstantin Mayer
István Vadász
Jesse D Roberts
Werner Seeger
Rory E Morty
Universities of Giessen and Marburg Lung Center · DEGerman Center for Lung Research · DEMassachusetts General Hospital · USMax Planck Institute for Heart and Lung Research · DE

Funding

Mechanisms regulating PKGI proteolysis and modulation of pulmonary SMC phenotypeR01HL096779 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ROBERTS, JESSE D · 2010 to 2013
$1.7M
NHLBI NIH HHS HL-094608NHLBI NIH HHS R01 HL096779
6 · The paper itself

Abstract

Bronchopulmonary dysplasia (BPD) is a common and serious complication of premature birth, characterized by a pronounced arrest of alveolar development. The underlying pathophysiological mechanisms are poorly understood although perturbations to the maturation and remodeling of the extracellular matrix (ECM) are emerging as candidate disease pathomechanisms. In this study, the expression and regulation of three members of the lysyl hydroxylase family of ECM remodeling enzymes (Plod1, Plod2, and Plod3) in clinical BPD, as well as in an experimental animal model of BPD, were addressed. All three enzymes were localized to the septal walls in developing mouse lungs, with Plod1 also expressed in the vessel walls of the developing lung and Plod3 expressed uniquely at the base of developing septa. The expression of plod1, plod2, and plod3 was upregulated in the lungs of mouse pups exposed to 85% O2, an experimental animal model of BPD. Transforming growth factor (TGF)-β increased plod2 mRNA levels and activated the plod2 promoter in vitro in lung epithelial cells and in lung fibroblasts. Using in vivo neutralization of TGF-β signaling in the experimental animal model of BPD, TGF-β was identified as the regulator of aberrant plod2 expression. PLOD2 mRNA expression was also elevated in human neonates who died with BPD or at risk for BPD, compared with neonates matched for gestational age at birth or chronological age at death. These data point to potential roles for lysyl hydroxylases in normal lung development, as well as in perturbed late lung development associated with BPD.

Indexed as

AnimalsAnimals, NewbornBronchopulmonary DysplasiaCell LineEpithelial CellsFemaleHumansHyperoxiaInfant, NewbornLungMaleMiceMice, Inbred C57BLPregnancyProcollagen-Lysine, 2-Oxoglutarate 5-DioxygenaseTransforming Growth Factor betalysyl hydroxylase 2, mouseProcollagen-Lysine, 2-Oxoglutarate 5-DioxygenaseTransforming Growth Factor betabronchopulmonary dysplasiaextracellular matrixlung developmentlysyl hydroxylase

Identifiers

PMID24285264
PMCPMC3920204
OpenAlexW2151080483

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.